Cardio-Oncology: Cancer Treatment and Your Heart

Clinical Trial Finder

This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Improving Survival in Lung Cancer Patients: A Trial of Aerobic Exercise and Tai-chi

Condition:   Survivorship
Intervention:   Behavioral: Aerobic Exercise, Tai chi
Sponsor:   The University of Hong Kong
Recruiting

PROstaTe Cancer - Exercise-STudy (PRO-TEST)

Condition:   Prostate Cancer
Interventions:   Behavioral: High Intensity Interval Training;   Behavioral: Usual Care Observational Control
Sponsor:   Rigshospitalet, Denmark
Active, not recruiting

Prevention of Cardiac Dysfunction During Breast Cancer Therapy

Conditions:   Breast Cancer Female;   Heart Failure
Intervention:   Drug: LCZ696
Sponsors:   Torbjorn Omland;   University Hospital, Akershus;   Oslo University Hospital;   University Hospital of North Norway;   St. Olavs Hospital;   Helse Stavanger HF;   KLINBEFORSK;   Norwegian Cancer Society;   Novartis
Recruiting

Thrombus Elastography in Venous Thrombo-Embolism.

Condition:   Venous Thromboembolism
Intervention:   Diagnostic Test: Ultrasound Elastography
Sponsor:   University Hospital, Brest
Recruiting

A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)

Condition:   Non-Small-Cell Lung
Interventions:   Drug: Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody;   Drug: Placebo Comparator;   Drug: Nab-paclitaxel;   Drug: Pemetrexed;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Gemcitabine
Sponsor:   Hoffmann-La Roche
Recruiting

A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer

Condition:   Carcinoma, Non-Small-Cell Lung
Interventions:   Drug: Alectnib;   Drug: Cisplatin;   Drug: Vinorelbine;   Drug: Gemcitabine;   Drug: Pemetrexed;   Drug: Carboplatin
Sponsor:   Hoffmann-La Roche
Recruiting

A Study in Participants Previously Enrolled in a Genentech− and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)

Condition:   Cancer
Intervention:   Drug: Atezolizumab
Sponsor:   Hoffmann-La Roche
Recruiting